Takahiko Bandou

Title: Takahiko Bandou: Innovator in Coagulation Time Determination

Introduction

Takahiko Bandou is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the determination of coagulation time. His innovative work has led to the development of a unique reagent that enhances the accuracy of coagulation tests.

Latest Patents

Takahiko Bandou holds a patent for a reagent designed for the determination of coagulation time. The patent, titled "Reagent for determination of coagulation time, production method therefor, reagent kit, and method for determination of coagulation time," discloses a reagent that includes phosphatidylcholine (PC), phosphatidylserine (PS), and phosphatidylethanolamine (PE). The concentration ratio of PS to PC is specified to be between 0.16 and 0.25, with PS concentrations ranging from 7 µg/mL to 13 µg/mL. This innovation is crucial for improving the accuracy of activated partial thromboplastin time tests.

Career Highlights

Takahiko Bandou is currently employed at Sysmex Corporation, a leading company in the field of medical diagnostics. His work at Sysmex has allowed him to focus on developing advanced diagnostic tools that benefit healthcare professionals and patients alike. With a patent portfolio that includes 1 patent, Bandou continues to push the boundaries of innovation in his field.

Collaborations

Takahiko Bandou collaborates with talented colleagues, including Kohei Akatsuchi and Naoki Yamamoto. Their combined expertise fosters a creative environment that drives the development of new technologies in medical diagnostics.

Conclusion

Takahiko Bandou's contributions to the field of coagulation time determination exemplify the impact of innovation in medical diagnostics. His work not only enhances testing accuracy but also supports better patient outcomes.